Osteoporosis drugs on every 2026 Illinois Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Illinois cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Wellcare Classic$0.00/moS4802-087 | Wellcare Value Script$0.00/moS4802-151 | Humana Basic Rx Plan$0.00/moS5884-107 | Humana Value Rx Plan$0.00/moS5884-196 | AARP Medicare Rx Saver from UHC$40.20/moS5921-362 | HealthSpring Extra Rx$66.60/moS5617-367 | Blue Cross MedicareRx Basic$89.70/moS5715-012 | SilverScript Choice$94.90/moS5601-034 | AARP Medicare Rx Preferred from UHC$103.90/moS5921-398 | HealthSpring Assurance Rx$104.20/moS5617-224 | Humana Premier Rx Plan$119.40/moS5884-163 | Blue Cross MedicareRx Value$119.70/moS5715-001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 2$1.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 2$8.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00QL 120/30d | Tier 1$0.00 | Tier 1$5.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 120/30d |
| risedronategeneric Actonel | Not covered | Tier 2$3.00QL 1/30d | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 433%QL 1/28d | Not covered | Not covered | Not covered | Tier 318%QL 1/28d |
| ibandronategeneric Boniva | Tier 325%QL 1/30d | Tier 2$3.00QL 1/30d | Tier 325%QL 1/28d | Tier 320%QL 1/28d | Tier 317%QL 1/28d | Tier 317%QL 1/28d | Tier 2$5.00QL 1/28d | Tier 433%QL 1/30d | Tier 317%QL 1/28d | Tier 321%QL 1/28d | Tier 3$45.00QL 1/28d | Tier 2$1.00QL 1/28d |
| Proliadenosumab | Not covered | Not covered | Tier 434%QL 1/180d | Tier 435%QL 1/180d | Not covered | Tier 430%QL 1/180d | Not covered | Not covered | Not covered | Tier 432%QL 1/180d | Tier 450%QL 1/180d | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Tier 431%QL 1/180d | Tier 440%QL 1/180d | Not covered | Not covered | Tier 439%QL 1/180d | Not covered | Tier 4PA43% | Tier 433%QL 1/180d | Tier 438%QL 1/180d | Not covered | Not covered | Tier 4PA32% |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Not covered | Not covered | Tier 5PA25%QL 2.24/28d | Tier 5PA26%QL 2.24/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA33%QL 2.24/28d | Not covered |
| teriparatidegeneric Forteo | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Not covered | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA25% | Tier 5PA31%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA25% |
| Tymlosabaloparatide | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Tier 5PA25% | Tier 5PA31%QL 1.56/30d | Not covered | Not covered | Tier 5PA25% |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.